PREMIX DRUG PRODUCT OF EDARAVONE

PROBLEM TO BE SOLVED: To provide a premix drug product of edaravone excellent in moldability and storage stability. SOLUTION: The premix drug product of the edaravone is formed of a multilayer film or multilayer sheet including a barrier layer with a thickness of 10 to 80 μm containing a cyclic poly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAGO SEIJI, SAKAGUCHI ITARU, FUKUSHIMA KIYOKO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a premix drug product of edaravone excellent in moldability and storage stability. SOLUTION: The premix drug product of the edaravone is formed of a multilayer film or multilayer sheet including a barrier layer with a thickness of 10 to 80 μm containing a cyclic polyolefin resin having a glass transition point of 70 to 110°C as a main component and a seal layer of a thickness of 5 to 80 μm arranged adjacent to the barrier layer and containing a polypropylene-based resin as a main component, wherein the seal layer forms the innermost layer, an aqueous drug product including the edaravone is accommodated in a plastic container having a seal portion sealed by seal layers facing each other, and the premix drug product of the edaravone is constituted by subjecting the same to high pressure steam sterilization in a hermetically sealed condition. COPYRIGHT: (C)2010,JPO&INPIT